• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏直视手术中肝素中和后增强的有效纤维蛋白溶解增加了术后出血的风险。

Enhanced effective fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of post-surgical bleeding.

作者信息

Gram J, Janetzko T, Jespersen J, Bruhn H D

机构信息

Department of Internal Medicine, Klinikum der Christian-Albrechts-Universität, Kiel, Federal Republic of Germany.

出版信息

Thromb Haemost. 1990 Apr 12;63(2):241-5.

PMID:2114043
Abstract

The tissue-type plasminogen activator related fibrinolytic system was studied in 24 patients undergoing cardiopulmonary bypass surgery. The degradation of fibrinogen and fibrin was followed during and after surgery by means of new sensitive and specific assays and the changes were related to the blood loss measured in the chest tube drain during the first 24 postoperative hours. Although tissue-type plasminogen activator was significantly released into the circulation during the period of extracorporeal circulation (p less than 0.01), constantly low levels of fibrinogen degradation products indicated that a systemic generation of plasmin could be controlled by the naturally occurring inhibitors. Following extracorporeal circulation heparin was neutralized by protamine chloride, and in relation to the subsequent generation of fibrin, there was a short period with increased concentrations of fibrinogen degradation products (p less than 0.01) and a prolonged period of degradation of cross-linked fibrin, as detected by increased concentrations of D-Dimer until 24 h after surgery (p less than 0.01). Patients with a higher than the median blood loss (520 ml) in the chest tube drain had a significantly higher increase of D-Dimer than patients with a lower than the median blood loss (p less than 0.05). We conclude that the incorporation of tissue-type plasminogen activator into fibrin and the in situ activation of plasminogen enhance local fibrinolysis, thereby increasing the risk of bleeding in patients undergoing open heart surgery.

摘要

对24例接受体外循环手术的患者的组织型纤溶酶原激活物相关纤溶系统进行了研究。在手术期间及术后,通过新的敏感且特异的检测方法追踪纤维蛋白原和纤维蛋白的降解情况,并将这些变化与术后24小时内胸腔引流管中测得的失血量相关联。尽管在体外循环期间组织型纤溶酶原激活物显著释放到循环中(p<0.01),但纤维蛋白原降解产物水平持续较低表明纤溶酶的全身生成可被天然存在的抑制剂控制。体外循环后,用氯化鱼精蛋白中和肝素,与随后的纤维蛋白生成相关,有一段短时间纤维蛋白原降解产物浓度升高(p<0.01),且交联纤维蛋白降解期延长,这通过术后24小时内D - 二聚体浓度升高得以检测(p<0.01)。胸腔引流管中失血量高于中位数(520毫升)的患者,其D - 二聚体升高幅度显著高于失血量低于中位数的患者(p<0.05)。我们得出结论,组织型纤溶酶原激活物掺入纤维蛋白以及纤溶酶原的原位激活增强了局部纤溶作用,从而增加了心脏直视手术患者出血的风险。

相似文献

1
Enhanced effective fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of post-surgical bleeding.心脏直视手术中肝素中和后增强的有效纤维蛋白溶解增加了术后出血的风险。
Thromb Haemost. 1990 Apr 12;63(2):241-5.
2
Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass.组织型纤溶酶原激活剂和纤维蛋白单体在体外循环后回输 shed blood 期间协同导致血小板功能障碍。 (注:shed blood 这里可能表述有误,不太明确准确意思,可根据实际情况修正)
J Thorac Cardiovasc Surg. 1993 Dec;106(6):1017-23.
3
Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass.体外循环期间心包腔内纤维蛋白溶解的激活。
J Thorac Cardiovasc Surg. 1993 Nov;106(5):828-33.
4
Hemostatic changes and clinical sequelae after on-pump compared with off-pump coronary artery bypass surgery: a prospective randomized study.体外循环与非体外循环冠状动脉搭桥术后止血变化及临床后遗症:一项前瞻性随机研究。
Coron Artery Dis. 2009 Mar;20(2):100-5. doi: 10.1097/MCA.0b013e3283219e8b.
5
Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.接受或未接受抑肽酶治疗的体外循环患者术后的止血与纤维蛋白溶解情况。
Thromb Haemost. 1994 Sep;72(3):438-43.
6
Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.不同程度肝硬化患者凝血激活导致的高纤溶状态。CALC研究组。肝硬化患者的凝血异常。
Hepatology. 1993 Jan;17(1):78-83.
7
The kinetics of plasmin inhibition by aprotinin in vivo.体内抑肽酶对纤溶酶的抑制动力学。
Thromb Res. 2005;115(4):327-40. doi: 10.1016/j.thromres.2004.09.015.
8
[Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].[冠状动脉溶栓治疗引起的止血和纤溶状态的系列变化]
J Cardiol. 1993;23(4):335-41.
9
Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system.小儿心脏手术期间止血的变化:生物相容性肝素涂层灌注系统的影响
Ann Thorac Surg. 2004 Mar;77(3):962-7. doi: 10.1016/j.athoracsur.2003.09.028.
10
Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.血管紧张素转换酶抑制对需要冠状动脉搭桥术患者纤溶系统的影响。
Thorac Cardiovasc Surg. 2009 Sep;57(6):368-71. doi: 10.1055/s-0029-1185596. Epub 2009 Aug 25.

引用本文的文献

1
An unusual clinical presentation resembling superior vena cava syndrome post heart surgery.一种类似心脏手术后上腔静脉综合征的不寻常临床表现。
Cardiovasc Ultrasound. 2005 Oct 3;3:31. doi: 10.1186/1476-7120-3-31.
2
Coagulation disorders of cardiopulmonary bypass: a review.体外循环凝血障碍:综述
Intensive Care Med. 2004 Oct;30(10):1873-81. doi: 10.1007/s00134-004-2388-0. Epub 2004 Jul 24.
3
The hemostatic defect of cardiopulmonary bypass.体外循环的止血缺陷。
J Thromb Thrombolysis. 2003 Dec;16(3):129-47. doi: 10.1023/B:THRO.0000024051.12177.e9.